Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

635 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The first echinocandin: caspofungin.
Cornely OA, Schmitz K, Aisenbrey S. Cornely OA, et al. Mycoses. 2002;45 Suppl 3:56-60. doi: 10.1111/j.1439-0507.2002.tb04771.x. Mycoses. 2002. PMID: 12690973 Review.
Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.
Raad II, Graybill JR, Bustamante AB, Cornely OA, Gaona-Flores V, Afif C, Graham DR, Greenberg RN, Hadley S, Langston A, Negroni R, Perfect JR, Pitisuttithum P, Restrepo A, Schiller G, Pedicone L, Ullmann AJ. Raad II, et al. Among authors: cornely oa. Clin Infect Dis. 2006 Jun 15;42(12):1726-34. doi: 10.1086/504328. Epub 2006 May 8. Clin Infect Dis. 2006. PMID: 16705579 Clinical Trial.
Second-line treatment in invasive mould infections.
Karthaus M, Cornely OA. Karthaus M, et al. Among authors: cornely oa. Mycoses. 2006;49 Suppl 1:23-6. doi: 10.1111/j.1439-0507.2006.01298.x. Mycoses. 2006. PMID: 16961578 Review.
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D. Cornely OA, et al. N Engl J Med. 2007 Jan 25;356(4):348-59. doi: 10.1056/NEJMoa061094. N Engl J Med. 2007. PMID: 17251531 Free article. Clinical Trial.
Treatment options in candidaemia.
Karthaus M, Cornely OA. Karthaus M, et al. Among authors: cornely oa. Mycoses. 2007;50 Suppl 1:44-9. doi: 10.1111/j.1439-0507.2007.01379.x. Mycoses. 2007. PMID: 17394609 Review.
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial.
Kuse ER, Chetchotisakd P, da Cunha CA, Ruhnke M, Barrios C, Raghunadharao D, Sekhon JS, Freire A, Ramasubramanian V, Demeyer I, Nucci M, Leelarasamee A, Jacobs F, Decruyenaere J, Pittet D, Ullmann AJ, Ostrosky-Zeichner L, Lortholary O, Koblinger S, Diekmann-Berndt H, Cornely OA; Micafungin Invasive Candidiasis Working Group. Kuse ER, et al. Among authors: cornely oa. Lancet. 2007 May 5;369(9572):1519-1527. doi: 10.1016/S0140-6736(07)60605-9. Lancet. 2007. PMID: 17482982 Clinical Trial.
Antifungal treatment strategies in high risk patients.
Rüping MJ, Vehreschild JJ, Cornely OA. Rüping MJ, et al. Among authors: cornely oa. Mycoses. 2008 Sep;51 Suppl 2:46-51. doi: 10.1111/j.1439-0507.2008.01572.x. Mycoses. 2008. PMID: 18721331
635 results